Home › NDC Lookup › Ingredients › Glycerin › 00132-0079-12
💊image loading
(from DailyMed)

Fleet Glycerin 2 g Suppository, 12 suppositories — NDC 0132-0079-12 (Billing 00132-0079-12)

by C.B. Fleet Company, Inc. · 12 SUPPOSITORY in 1 JAR

This is a package of 12 suppositories of Fleet Glycerin 2 g Suppository from C.B. Fleet Company, Inc., no longer marketed, no longer in the FDA NDC Directory; retail pharmacies pay about $0.1000 per suppositorie (NADAC).

NDC 00132-0079-12
🏷️ FDA NDC (as labeled) 0132-0079-12 billing pads the labeler segment with a zero
This package
Contains12 suppositories Cost per ea$0.1000 NADAC Per package$1.20 / 12 suppositories Pack sizes4 compare ↓
Product page 00132-0079-00 Also comes in: 24 suppositories 0132-0079-24 50 suppositories 0132-0079-50 100 suppositories 0132-0079-00
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0132-0079-12 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0132 labeler · 0079 product · 12 package
Billing quantity
12 EA per package
Barcode (UPC-A, from the NDC)
3 0132007912 8
FDA record last changed
Jul 17, 2026
⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Apr 2023. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0132-0079-12
Product NDC 0132-0079
11-digit billing NDC 00132007912
NCPDP billing unit EA — each (per item)
Application # part334
Established class (EPC) Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH NOT FINAL
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Apr 2023)
Route RECTAL
Dosage form SUPPOSITORY
Substance GLYCERIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46600010005215
GCN Seq No 002982
GCN 08860
HICL code 001312
Ingredient (HICL) Glycerin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FLEET GLYCERIN 2 GM ADULT SUPP
FDB brand name Adult Glycerin
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002982
  • GCN: 08860
  • GPI-14 (Medi-Span): 46600010005215
  • HICL (First Databank): 001312
  • AHFS class code: 56:12.00.00
Why two NDCs? The FDA registers this code as 0132-0079-12 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0079-12. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name FLEET GLYCERIN 2 GM ADULT SUPP Ingredient Glycerin
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.100 $1.20 / 12 suppositories
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Nov 2025 Jan 2026 $0.101 $0.100
Flat over the last 2 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00132-0079-24 0132-0079-24 24 SUPPOSITORY in 1 JAR $0.0960 / ea $2.30 1984-11-01 — Discontinued by firm
00132-0079-12 You're viewing this 12 SUPPOSITORY in 1 JAR $0.1000 / ea $1.20 1984-11-01 — Discontinued by firm
00132-0079-50 0132-0079-50 50 SUPPOSITORY in 1 JAR $0.0643 / ea $3.21 1984-11-01 — Discontinued by firm
00132-0079-00 0132-0079-00 Main listing 100 SUPPOSITORY in 1 JAR $0.0643 / ea $6.43 1984-11-01 — Discontinued by firm

You're viewing the smallest of 4 pack sizes for this product.

Per ea, this pack runs about 56% above the cheapest pack (50-count, $0.0643 vs $0.1000 NADAC).

Pack size FAQ

What quantity is in this package?
This package contains 12 suppositories — 12 suppository in 1 jar.
How does this package differ from NDC 00132-0079-24?
Both are Fleet Glycerin 2 g Suppository — the drug itself is identical. This page's package is the 12 suppositories one, while NDC 00132-0079-24 is the 24 suppositories package. Per-ea NADAC also differs: $0.1000 here vs $0.0960 for the 24 suppositories pack.
What NDC number is used to bill for this package of Fleet Glycerin 2 g Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fleet 2 gthis 00132-0079-12 C.B. 12 suppositories $0.100 — Discontinued —
Glycerin 2 g 70000-0572-01 Cardinal 25 suppositories $0.103 — Availability likely +3%
Glycerin 2 g 57237-0325-21 Rising 12 suppositories $0.217 — Availability likely +117%
Proctozone GMax 2 g 57237-0339-21 Rising 12 suppositories $0.217 — Availability likely +117%
Fleet 2 g 00132-0075-00 C.B. 100 suppositories — — FDA listed —
Walgreens Adult Glycerin Laxative 2 g 00363-0445-25 Walgreens 62.5 g — — FDA listed —
Glycerin 2 g 11822-3312-05 Rite 50 suppositories — — FDA listed —
Rite-Aid Glycerin Laxative 2 g 11822-9100-00 RITE 100 suppositories — — FDA listed —
Glycerin Laxative 2 g 13709-0322-01 NeilMed 25 capsules — — FDA listed —
Glycerin Laxative 2 g/2.5g 13709-0329-01 Neilmed 2.5 g — — FDA listed —
Glycerin 2 g 37808-0398-50 H 50 suppositories — — FDA listed —
Stratuscare Adult Glycerin 2 g 58980-0410-12 Stratus 12 suppositories — — FDA listed —
CVS Pharmacy Glycerin Laxative 2 g 59779-0109-50 CVS 50 suppositories — — FDA listed —
Glycerin 2 g 68016-0015-79 Chain 25 suppositories — — FDA listed —
Glycerin 2 g 69842-0724-10 CVS 100 suppositories — — FDA listed —
Bliss GVS 2 g 72701-0106-05 Bliss 100 suppositories — — FDA listed —
Glycerin 2 g 84415-0039-50 Everpharm 50 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerC.B. Fleet Company, Inc.
FDA applicationpart334 (OTC MONOGRAPH NOT FINAL)
Labeler code00132
Product typeHuman Otc Drug
Portfolio23 products on file

More NDCs from C.B. Fleet Company, Inc. labeler code 00132

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA.
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Not Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no full label on this page?
No structured FDA label (SPL) is currently linked to this NDC in DailyMed/openFDA. That can happen with older listings, certain OTC and repackaged products, and recently updated listings whose label has not yet propagated. The listing itself is still valid — this page shows everything the public feeds provide for this package.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 24 suppositories (00132-0079-24), 50 suppositories (00132-0079-50), 100 suppositories (00132-0079-00). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
C.B. Fleet Company, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00132-0078-01 · C.B. 00132-0113-24 · C.B. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.